Impact of Dasatinib and Etoposide on ALDH1-Positive Cell Proportions in Cancer Treatment

DESCRIPTION

This study investigates the effects of Dasatinib and Etoposide at a concentration of 0.1μM on the proportion of ALDH1-positive cells. The data compares control groups with and without DEAB, revealing that treatment with Dasatinib and Etoposide resulted in ALDH1-positive cell proportions of 5.25% and 3.49%, respectively. In contrast, control groups exhibited significantly lower proportions of ALDH1-positive cells, highlighting the influence of these drugs on cancer cell populations and suggesting potential pathways for enhancing cancer therapies.

Download

1 / 1

Mar 18, 2014

Télécharger la présentation

Impact of Dasatinib and Etoposide on ALDH1-Positive Cell Proportions in Cancer Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Dasatinib + etoposide 0.1μM dasatinib 0.1μM Eto Control With DEAB Without DEAB The proportion of ALDH1-positive 5.25% 3.49% 7.81% 3.29%

More Related